MYX 2.11% $4.17 mayne pharma group limited

Ann: FDA approval of novel oral contraceptive NEXTSTELLIS, page-46

  1. 192 Posts.
    lightbulb Created with Sketch. 60
    Most definitely. However, I think a large factor in the downward pressure will be relieved LT holders who are exiting. I haven't sold a share yet, and I'll be watching it closely over the next week.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.